UK Edition

Tuesday, 27 October 2026

Markets Brief

News, business, world affairs and market coverage

Trading

Galderma Highlights Recent Restylane Approvals At 30-Year Mark

Markets Brief, UK brief (2026-10-06): (RTTNews) - Galderma Group AG (GALD.SW, GDERF) announced that its Restylane injectable aesthetic product line has reached its 30th anniversary since its… Primary source: original at Nasdaq Market Structure (nasdaq.com).

Galderma Highlights Recent Restylane Approvals At 30-Year Mark

(RTTNews) - Galderma Group AG (GALD.SW, GDERF) announced that its Restylane injectable aesthetic product line has reached its 30th anniversary since its European launch. Restylane, which was introduced as a hyaluronic acid injectable, has since expanded into a portfolio of produc

Read at source